The constancy of the internal environment is in itself evidence that physiological agencies are acting, or ready to act, to maintain this constancy. W.B. Cannon (1)
CannonW.B.The Wisdom of the Body.London: Kegan Paul and Company, 1932.
2.
DobbieJ.M., ZakiM., WilsonL.Ultrastructural studies of the peritoneum with special reference to chronic ambulatory peritoneal dialysis.Scott Med1981; 26: 213–23.
3.
VergerC., BrunschvicgO., Le CharpentierY., LavergneA., VantelonJ.Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.Proc EDTA1981; 18: 199–205.
4.
Di PaoloN., SacchiG., De MiaM.Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis.Nephron1986; 44: 204–11.
5.
GotloibL., ShostakA., Bar-SellaP., CohenR.Continuous mesothelial injury and regeneration during long-term peritoneal dialysis.Perit Dial Bull1987; 7: 148–55.
6.
DuweA.K., VasS.I., WeatherheadJ.W.Effects of the composition of peritoneal dialysis fluid on chemiluminiscence, phagocytosis, and bactericidal activity in vitro.Infect Immun1981; 33: 130–5.
7.
GagnonR.F., ObstG., RichardsG.K., GervaisF.Effect of drug additives to peritoneal dialysis solutions on the viability and function of mouse peritoneal cells.Nephron1990; 56: 201–5.
8.
Van BronswijkH., VerbroughM.A., BosH.J.Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro.Perit Dial Int1989; 9: 197–202.
9.
TopleyN., MackenzieR., PetersenM.M.In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid.Nephrol Dial Transplant1991; 6: 574–81.
10.
WitowskiJ., TopleyN., JörresA., LiberekT., ColesG.A., WilliamsJ.D.Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.Kidney Int1995; 47: 282–93.
11.
BreborowiczA.In vitro study on the biocompatibility of the peritoneal dialysis solution.Perit Dial Int1992; 13(Suppl 2): S105–8.
12.
BreborowiczA., RodelaH., MartisL., OreopoulosD.G.Lactate at acid pH is responsible for the decrease in intracellular glutathione (GSH) of mesothelial cells (MC) exposed to dialysis solutions.Perit Dial Int1995; 15(Suppl 1): S68.
13.
ShostakA., PivnikE., GotloibL.Cultured rat mesothelial cells generate hydrogen peroxide. A new player in peritoneal defense?J Am Soc Neph. In press.
14.
TopleyN., KaurD., PetersenM.M.In vitro effect of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.J Am Soc Neph1996; 7: 218–24.
15.
ChaimovitzC., RapaportJ., KonfortiJ., DouvdevaniA.Commercial dialysis fluid causes intracellular acidosis in peritoneal macrophages.J Am SocNeph1992; 3: 407–12.
16.
KristensenS.R., PedersenF.B.Cytotoxicity testing of two CAPD fluids in a model system of quiescent fibroblasts.Nephrol Dial Transplant1993; 8: 163–7.
17.
DouvdevaniA., RapaortJ., KonfortiA., ZlotnikM., ChaimovitzC.The effect of peritoneal dialysis fluid on the release of IL-1 beta and TNF-alpha by macrophages/monocytes.Perit Dial Int1993; 13: 112–7.
18.
LiberekT., TopleyN., JorresA., ColesG.A., GahlG.M., WilliamsJ.D.Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration.J Am Soc Neph1993; 3: 1508–15.
19.
JorresA., JorresD., GahlG.M.Leukotrienne B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate.Nephron1991; 58: 276–82.
20.
BreborowiczA., RodelaH., OreopoulosD.G.Toxicity of osmotic solutes on human mesothelial cells in vitro.Kidney Int1992; 41: 1280–5.
21.
KumanoK., Schiller-MoranB., HjelleJ.T., MoranJ.Hypertonic glucose decreases total protein synthesis but increases fibronectin (FN) gene expression on cultured rat mesothelial cells (RMC).Perit Dial Int1994; 14(Suppl 1): S5.
22.
Di PaoloN., GarosiG., PetriniG., MonaciG.Morphological and morphometric changes in mesothelial cells during peritoneal dialysis in the rabbit.Nephron1996; 74: 594–9.
23.
MartinsonE., WieslanderA., KjellstrandP., BobergV.Toxicity of heat sterilized peritoneal dialysis fluids is derived from the degradation of glucose.ASAIO1992; 38: M370–2.
24.
EfskindL.Experimentelle untersuchungen uber die biologie desperitoneums. I. Die morphologische reaktion desperitoneumsaufreize.Oslo: DetMorske Videnskaps Akademii, 1940.
25.
GotloibL., ShostakA., WajsbrotV., KushnierR.Biocompatibility of dialysis solutions evaluated by histochemical techniques applied to mesothelial cell imprints.Perit Dial Int1993; 13(Suppl 2): SH3–5.
26.
GotloibL., ShostakA.Large mesothelial cells in peritoneal dialysis: a sign of degeneration or adaptation?Perit Dial Int1996; 16: 118–20.
27.
GotloibL., WajsbrotV., ShostakA., KushnierR.Acute and long term changes observed in imprints of mice mesothelium exposed to glucose enriched, lactated buffered dialysis solutions.Nephron1995; 70: 466–77.
28.
NolphK.D., TwardowskiZ.I., PopovichR.P., RubinJ.Equilibration of peritoneal dialysis solutions during long dwell exchanges.J Lab Clin Med1979; 93: 246–56.
29.
GotloibL., WajsbrotV., ShostakA., KushnierR.Population analysis of mesothelium, in-situ and in-vivo exposed to bicarbonate buffered peritoneal dialysis fluid.Nephron1996; 73: 219–27.
30.
RoseB.D.Clinical physiology of acid-base and electrolyte disorders.New York: McGraw Hill, 1994: 297.
31.
StoutR.W.Glucose inhibits replication of cultured human endothelial cells.Diabetologia1982; 23: 436–9.
32.
LorenziM., NordbergJ.A., ToledoS.High glucose prolongs cell-cycle traversal of cultured human endothelial cells.Diabetes1987; 36: 1261–7.
33.
MorocuttiA., EarleK.A., SethiM.Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease.Kidney Int1996; 50: 250–6.
34.
LorenziM., GaglieroE., ToledoS.Glucose toxicity for human endothelial cells in culture.Diabetes1985; 34: 621–7.
35.
GotloibL., ShostakA.Endocytosis and transeytosis of albumin gold through mice peritoneal mesothelium.Kidney Int1995; 47: 1274–84.
36.
WitowskiJ., TopleyN., JorresA., LiberekT., ColesG.A., WilliamsJ.D.Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.Kidney Int1994; 46: 282–93.
37.
MuijskenM.A., HeeziusH.J., VerhoefJ., VerbrughH.A.Role of mesothelial cells in peritoneal antibacterial defense.J Clin Pathol1991; 44: 600–4.
38.
VanholderR., LameireN., WaterlocsM.A.Disturbed host defense in peritoneal cavity during CAPD: characterization dialysis of responsible factors in dwell fluid.Kidney Int1996; 50: 643–52.
